SMITH, ANDREW
 Distribuzione geografica
Continente #
NA - Nord America 17.122
AS - Asia 10.866
EU - Europa 8.473
SA - Sud America 1.369
Continente sconosciuto - Info sul continente non disponibili 991
AF - Africa 207
OC - Oceania 34
Totale 39.062
Nazione #
US - Stati Uniti d'America 16.088
IT - Italia 3.343
VN - Vietnam 3.094
SG - Singapore 3.079
CN - Cina 2.024
HK - Hong Kong 1.089
BR - Brasile 994
DE - Germania 933
RU - Federazione Russa 865
CA - Canada 770
SE - Svezia 664
IE - Irlanda 648
GB - Regno Unito 453
FR - Francia 330
IN - India 312
BD - Bangladesh 256
AT - Austria 250
UA - Ucraina 192
KR - Corea 167
NL - Olanda 131
FI - Finlandia 130
AR - Argentina 122
ID - Indonesia 119
TR - Turchia 118
ES - Italia 104
IQ - Iraq 99
DK - Danimarca 95
JP - Giappone 87
ZA - Sudafrica 74
MX - Messico 73
CH - Svizzera 70
PL - Polonia 66
EC - Ecuador 61
VE - Venezuela 54
PK - Pakistan 50
PH - Filippine 47
SA - Arabia Saudita 47
CO - Colombia 45
BE - Belgio 35
CR - Costa Rica 35
MY - Malesia 33
AU - Australia 32
IR - Iran 30
PY - Paraguay 30
UZ - Uzbekistan 29
LT - Lituania 28
MA - Marocco 27
SV - El Salvador 26
TW - Taiwan 23
CL - Cile 20
JM - Giamaica 20
TN - Tunisia 20
TT - Trinidad e Tobago 19
PE - Perù 18
GT - Guatemala 17
JO - Giordania 17
PR - Porto Rico 17
TH - Thailandia 17
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 16
GR - Grecia 16
UY - Uruguay 15
DZ - Algeria 14
EG - Egitto 14
IL - Israele 14
NP - Nepal 14
HN - Honduras 13
KE - Kenya 13
KZ - Kazakistan 13
RO - Romania 13
OM - Oman 11
ET - Etiopia 10
NO - Norvegia 10
AZ - Azerbaigian 9
HR - Croazia 9
NI - Nicaragua 9
PT - Portogallo 9
BG - Bulgaria 8
BO - Bolivia 8
HU - Ungheria 8
KG - Kirghizistan 8
LB - Libano 8
PA - Panama 8
AL - Albania 7
CW - ???statistics.table.value.countryCode.CW??? 7
DO - Repubblica Dominicana 7
GP - Guadalupe 7
LV - Lettonia 7
PS - Palestinian Territory 7
BY - Bielorussia 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
MN - Mongolia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BB - Barbados 4
CI - Costa d'Avorio 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
EE - Estonia 3
Totale 38.013
Città #
Ashburn 1.825
Singapore 1.745
Ann Arbor 1.699
San Jose 1.342
Milan 1.242
Hong Kong 1.047
Ho Chi Minh City 939
Hanoi 726
Dublin 630
Council Bluffs 601
Frankfurt am Main 594
Fairfield 585
Chandler 582
Toronto 496
Wilmington 460
New York 429
Santa Clara 370
Woodbridge 367
Houston 354
Los Angeles 351
Dearborn 306
Dallas 305
Seattle 278
Beijing 258
Chicago 243
Vienna 210
Hefei 201
Rome 201
Princeton 194
Cambridge 185
Shanghai 163
The Dalles 163
Jacksonville 156
Seoul 145
Nanjing 135
Buffalo 132
São Paulo 129
Lauterbourg 115
Columbus 111
Dong Ket 111
Da Nang 101
Phoenix 96
Boardman 95
Moscow 93
Helsinki 78
Ha Long 73
Haiphong 72
Orem 71
Montreal 66
Hải Dương 65
Turin 64
London 63
Quận Bình Thạnh 63
Jakarta 62
Kent 61
Atlanta 59
Biên Hòa 57
Brooklyn 57
Denver 55
Guangzhou 55
Tokyo 55
Chennai 53
Washington 52
Philadelphia 51
Lawrence 49
Lissone 48
Thái Nguyên 48
Nuremberg 47
Warsaw 47
Nanchang 46
Baghdad 44
San Diego 44
Munich 43
Vũng Tàu 43
Manchester 42
Altamura 41
Can Tho 41
Naples 40
Ninh Bình 40
Shenyang 40
Bắc Ninh 38
Falls Church 37
Johannesburg 36
Newark 36
Sesto San Giovanni 36
Stockholm 35
Florence 34
Poplar 34
Zurich 34
Salt Lake City 33
Bắc Giang 32
Fremont 32
Basingstoke 31
Changsha 31
Ottawa 31
Amsterdam 30
Bologna 29
Hebei 29
Pune 29
Zhengzhou 29
Totale 23.101
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 637
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 628
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 595
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 577
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 537
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 499
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 491
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 486
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 479
The putative role of MALDI-MSI in the study of Membranous Nephropathy 465
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 463
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 456
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 442
The proteomic landscape of renal tumors 435
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 432
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 430
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 421
MALDI imaging in Fabry nephropathy: a multicenter study 421
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 416
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 412
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 409
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 403
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 403
Proteomics for the diagnosis of thyroid lesions: Preliminary report 402
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 400
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 395
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 394
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 393
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 387
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 384
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 384
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 377
Proteomics for the study of new biomarkers in Fabry disease: State of the art 367
Proteome analysis in thyroid pathology 363
Tumor size, stage and grade alterations of urinary peptidome in RCC 360
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 353
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 352
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 352
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 341
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 338
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 337
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 335
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 321
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 319
A molecular imaging approach to individuate tumour infiltrating lymphocytes 318
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 314
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 314
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 311
Intraluminal proteome and peptidome of human urinary extracellular vesicles 311
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 309
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 302
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 298
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 296
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 291
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 281
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 281
Machine learning approaches in MALDI-MSI: clinical applications 280
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 276
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 273
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 271
MALDI-MS imaging in the study of glomerulonephritis 270
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 269
The role of fine needle aspiration of orbital lesions: A case series 267
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 266
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 266
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 259
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 259
Single-follicle spatial proteomics of the whole ovary by MALDI mass spectrometry imaging: towards the identification of protein-markers of the follicle's quality 256
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 254
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 254
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 248
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 247
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 245
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 236
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 233
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 233
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 232
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 230
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 228
The putative role of MALDI-MSI in the study of Membranous Nephropathy 226
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 222
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 220
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 219
The putative role of MALDI-MSI in the study of Membranous Nephropathy 218
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 216
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 215
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 214
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 213
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 212
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 212
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 209
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 206
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 205
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 203
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 202
Enhanced Detection of Escherichia coli Lipids and Proteins Using Graphene-Polyglycerol Amine via Mass Spectrometry 202
Multi-omic and multimodal characterization of thyroid nodules: novel interplay between molecular and morphological features 201
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 200
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 199
Does the urinary proteome reflect ccrcc stage and grade progression? 194
Totale 32.477
Categoria #
all - tutte 115.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.139 0 0 0 162 114 145 39 83 61 113 149 273
2022/20232.579 300 692 242 199 101 394 47 200 172 37 113 82
2023/20242.140 75 85 82 145 198 585 438 52 132 36 82 230
2024/20255.111 226 452 344 214 439 183 310 196 600 785 567 795
2025/202616.293 2.847 1.521 1.056 1.547 1.540 639 1.987 650 1.050 1.246 1.025 1.185
2026/20274.554 561 657 1.603 1.733 0 0 0 0 0 0 0 0
Totale 39.062